LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

NCT02059057 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2021-07-19

Study results available
· View outcomes & findings →

Summary

Crossover study for patients who were randomized to the Control Group in CLN0009 (NCT01608490).

Conditions

  • Emphysema

Interventions

DEVICE

LVRC System

Sponsors & Collaborators

  • PneumRx, Inc.

    collaborator INDUSTRY
  • Boston Scientific Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
36 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-06-30
Completion
2019-07-26

Countries

  • United States
  • Canada
  • France
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02059057 on ClinicalTrials.gov